Literature DB >> 26844792

Clinical Experience With High-Dosage Pramipexole in Patients With Treatment-Resistant Depressive Episodes in Unipolar and Bipolar Depression.

Jan Fawcett1, A John Rush1, John Vukelich1, Shanna H Diaz1, Lucas Dunklee1, Paul Romo1, Brandon C Yarns1, Rodrigo Escalona1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26844792     DOI： 10.1176/appi.ajp.2015.15060788

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  27 in total

1.  Pramipexole in Treatment Resistant-Depression, Possible Role of Inflammatory Cytokines.

Authors:  Rodrigo Escalona; Jan Fawcett
Journal:  Neuropsychopharmacology       Date:  2017-01       Impact factor: 7.853

2.  Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial.

Authors:  Manish K Jha; Abu Minhajuddin; Bharathi S Gadad; Tracy Greer; Bruce Grannemann; Abigail Soyombo; Taryn L Mayes; A John Rush; Madhukar H Trivedi
Journal:  Psychoneuroendocrinology       Date:  2017-01-24       Impact factor: 4.905

Review 3.  Dopaminergic impact of cART and anti-depressants on HIV neuropathogenesis in older adults.

Authors:  Stephanie M Matt; Peter J Gaskill
Journal:  Brain Res       Date:  2019-08-21       Impact factor: 3.252

4.  DRD3 (dopamine receptor D3) but not DRD2 activates autophagy through MTORC1 inhibition preserving protein synthesis.

Authors:  Pedro Barroso-Chinea; Diego Luis-Ravelo; Felipe Fumagallo-Reading; Javier Castro-Hernandez; Josmar Salas-Hernandez; Julia Rodriguez-Nuñez; Alejandro Febles-Casquero; Ignacio Cruz-Muros; Domingo Afonso-Oramas; Pedro Abreu-Gonzalez; Rosario Moratalla; Mark J Millan; Tomas Gonzalez-Hernandez
Journal:  Autophagy       Date:  2019-10-02       Impact factor: 16.016

Review 5.  Inflammation Effects on Motivation and Motor Activity: Role of Dopamine.

Authors:  Jennifer C Felger; Michael T Treadway
Journal:  Neuropsychopharmacology       Date:  2016-08-02       Impact factor: 7.853

6.  Toward precision medicine for depression: admitting ignorance and focusing on failures.

Authors:  A John Rush
Journal:  World Psychiatry       Date:  2016-10       Impact factor: 49.548

7.  Interleukin 17 selectively predicts better outcomes with bupropion-SSRI combination: Novel T cell biomarker for antidepressant medication selection.

Authors:  Manish K Jha; Abu Minhajuddin; Bharathi S Gadad; Tracy L Greer; Taryn L Mayes; Madhukar H Trivedi
Journal:  Brain Behav Immun       Date:  2017-07-08       Impact factor: 7.217

8.  Experimental Therapies for Treatment-Resistant Depression: "How do you decide when to go to an unproven or experimental therapy with patients that are treatment-resistant depression?"

Authors:  Manish K Jha; Madhukar H Trivedi
Journal:  Focus (Am Psychiatr Publ)       Date:  2018-07-18

9.  Lower CSF homovanillic acid relates to higher burden of neuroinflammation and depression in people with HIV disease.

Authors:  Rowan Saloner; Mariana Cherner; David J Grelotti; Emily W Paolillo; David J Moore; Robert K Heaton; Scott L Letendre; Adarsh Kumar; Igor Grant; Ronald J Ellis
Journal:  Brain Behav Immun       Date:  2020-09-20       Impact factor: 7.217

10.  Baseline reward processing and ventrostriatal dopamine function are associated with pramipexole response in depression.

Authors:  Alexis E Whitton; Jenna M Reinen; Mark Slifstein; Yuen-Siang Ang; Patrick J McGrath; Dan V Iosifescu; Anissa Abi-Dargham; Diego A Pizzagalli; Franklin R Schneier
Journal:  Brain       Date:  2020-02-01       Impact factor: 13.501
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.